Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dolder is a prominent Swiss distributor of specialty chemicals and raw materials, serving the life sciences, plastics, and industrial sectors. Established in 1898 and based in Basel, the company acts as a strategic link between global chemical producers and the processing industry. Within the healthcare sector, Dolder focuses on providing high-quality active pharmaceutical ingredients (APIs), excipients, and intermediates. The firm offers value-added services including regulatory compliance support, technical consulting, and sophisticated supply chain solutions. As an independent, family-owned business, Dolder maintains a strong international footprint with operations across Europe and Asia. Their expertise in the life sciences segment ensures that pharmaceutical manufacturers receive materials that meet stringent international quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dolder.